PANCREATIC CARCINOMA
Clinical trials for PANCREATIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC CARCINOMA trials appear
Sign up with your email to follow new studies for PANCREATIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets tough pancreatic cancer gene
Disease control Not yet recruitingThis study tests a new drug called DN022150 combined with standard chemotherapy (AG) as a first treatment for advanced pancreatic cancer that has a specific genetic change called KRAS G12D. About 465 adults aged 18-75 who have not had prior treatment for advanced disease will tak…
Matched conditions: PANCREATIC CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: Jiangxi Kvvit Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug targets tough cancers with KRas G12V mutation
Disease control Not yet recruitingThis early-phase trial tests an experimental drug called CLSP-5282 in up to 140 adults with advanced solid tumors (like lung, pancreatic, or colorectal cancer) that have a specific genetic change called KRas G12V. The drug is given by IV infusion. The main goals are to check safe…
Matched conditions: PANCREATIC CARCINOMA
Phase: PHASE1 • Sponsor: Clasp Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC